Research Peptides in Australia: Complete Guide (2026)

Research peptides are short-chain amino acid sequences synthesised for use in scientific investigation, typically in vitro (cell culture) and preclinical (animal model) research contexts. Unlike therapeutic drugs, research peptides are not approved medicines; they are tools for investigating biological mechanisms at the molecular and cellular level.

Peptides are distinguished from proteins by length: conventionally, chains of fewer than 50 amino acids are classified as peptides. Their small size generally confers high receptor specificity and relatively low immunogenicity compared to larger biologics, making them valuable research tools for characterising specific signalling pathways.

In Australia, research peptides are supplied for laboratory use only and are not listed on the Australian Register of Therapeutic Goods (ARTG) as approved medicines. See: Are Research Peptides Legal in Australia?

Research peptides are broadly grouped by their primary mechanism or research application:

The GLP-1 receptor agonist class is the most clinically advanced peptide category, with multiple Phase 3-approved compounds (semaglutide, tirzepatide) and emerging next-generation agents in development. These compounds act on the incretin system to modulate insulin secretion, appetite, gastric emptying, and energy balance.

• Retatrutide (GLP-1/GIP/glucagon triple agonist), Phase 2 data shows ~24.2% mean weight reduction at 48 weeks; Phase 3 TRIUMPH programme ongoing. Available in 20mg and 30mg vials.
• Tirzepatide (GLP-1/GIP dual agonist), FDA/TGA-approved; extensive Phase 3 SURMOUNT data. Available in 30mg vials.
• Semaglutide, most characterised GLP-1 compound; SUSTAIN, STEP and SELECT trial datasets spanning 5+ years.

Tissue repair peptides are studied for their effects on wound healing, tendon repair, angiogenesis, and gastrointestinal health. The two most studied compounds in this category are often used in combination:

• BPC-157, Body Protection Compound-157; 15-amino-acid pentadecapeptide with extensive preclinical data on soft tissue, bone, and gut healing. Available in 20mg vials.
• TB-500, Thymosin Beta-4 fragment; studied for systemic cell migration, actin regulation, and regenerative signalling. Available in 10mg vials.
• BPC-157 + TB-500 Combination, frequently studied together for complementary tissue repair mechanisms; available as a pre-formulated 10mg blend.

GH secretagogues and GHRH analogues are studied for their ability to modulate the growth hormone/IGF-1 axis. Unlike exogenous HGH, secretagogues work by stimulating endogenous GH secretion:

• Ipamorelin, selective GHRP with minimal cortisol/prolactin effect; frequently combined with CJC-1295 for synergistic pulsatile GH release. Available in 10mg vials.
• CJC-1295, DAC-modified GHRH analogue with extended half-life; available individually (10mg) or as a CJC-1295/Ipamorelin blend.
• Tesamorelin, TGA-recognised GHRH analogue with FDA approval for HIV-associated lipodystrophy. Available in 10mg vials.
• HGH (Somatotropin), recombinant human growth hormone; extensively characterised in clinical literature. Available in 10IU, 24IU, and 40IU kits.

Mitochondrial dysfunction is central to multiple hallmarks of ageing. A growing class of peptides targets mitochondrial pathways directly:

• MOTS-c, mitochondria-derived peptide; studies show improved insulin sensitivity and exercise capacity in aged models. Available in 10mg and 40mg vials.
• SS-31 (Elamipretide), inner mitochondrial membrane-targeted tetrapeptide; Phase 2/3 clinical trial data for heart failure and mitochondrial myopathy. Available in 10mg and 50mg vials.
• NAD+, central metabolic coenzyme; studied for sirtuin activation, mitochondrial biogenesis, and DNA repair. Available in 100mg and 500mg vials.
• Epitalon, tetrapeptide studied for telomerase activation and longevity biomarkers. Available in 10mg vials.

Several neuropeptides of Russian origin have been studied in both clinical and preclinical settings for cognitive, anxiolytic, and neuroprotective applications:

• Semax, ACTH-derived nootropic; BDNF upregulation and dopaminergic modulation; Russian clinical approval. Available in 10mg vials.
• Selank, tuftsin analogue with GABA-A and enkephalin modulation; Russian clinical approval as anxiolytic. Available in 10mg vials.
• DSIP, Delta Sleep-Inducing Peptide; studied for sleep modulation and stress adaptation. Available in 10mg vials.
• KPV, tripeptide fragment of alpha-MSH; studied for anti-inflammatory and gut mucosal research. Available in 10mg vials.

Quality is the primary variable in research peptide sourcing. Key indicators:

1. Lyophilised formulation, freeze-dried powder is more stable than pre-mixed solution; avoid suppliers selling liquid peptides, which degrade faster
2. Purity ≥98%, verified by HPLC (high-performance liquid chromatography) analysis; ask for supplier Certificate of Analysis (CoA)
3. Australian fulfilment, local stock means 2–5 business day delivery and no customs delays; international orders risk confiscation and significant delays
4. Transparent product information, molecular weight, amino acid sequence, CAS number, and storage requirements should all be listed
5. Crypto payment options, most Australian research peptide suppliers accept cryptocurrency (LTC, XMR, BTC) due to payment processor restrictions on research compounds

OzPeps stocks research-grade peptides from Australian fulfilment with HPLC-verified purity, Australia-wide shipping, and crypto payment acceptance (LTC, XMR, BTC). Browse the full catalogue →

Lyophilised peptides require reconstitution with a suitable solvent before use in research protocols. Standard practice:

• Use bacteriostatic water (0.9% benzyl alcohol) as the reconstitution solvent, this inhibits microbial growth and extends vial stability across multiple withdrawals
• Inject the water slowly down the inside vial wall; do not inject directly onto the powder
• Swirl gently, do not shake (peptides can denature under mechanical stress)
• Store reconstituted vials at 2–8°C; label with date of reconstitution
• Most reconstituted peptides are stable for 28–42 days at 2–8°C depending on compound

Use the OzPeps reconstitution calculator to calculate the exact bacteriostatic water volume needed for your target concentration.

Full protocol: Bacteriostatic Water & Peptide Reconstitution Guide →

Australian research peptide suppliers typically cannot accept credit card or bank transfer payments due to restrictions from payment processors and banks on research compounds. Cryptocurrency is the standard payment method:

• Litecoin (LTC), fast transactions, low fees; most widely supported at Australian peptide suppliers
• Monero (XMR), privacy-focused; accepted by OzPeps
• Bitcoin (BTC), widely accepted; higher fees and slower confirmation times than LTC

For a step-by-step guide to setting up a crypto wallet and making your first purchase, see: How to Set Up a Crypto Wallet in Australia →

OzPeps accepts LTC, XMR, and BTC via BTCPay Server, a self-hosted, non-custodial payment processor. See: How to Pay at OzPeps →

Research peptides occupy a distinct regulatory space in Australia: they are not individually scheduled under the TGA Poisons Standard for research supply purposes, but they are not approved therapeutic goods and cannot legally be sold as medicines or supplements.

OzPeps supplies all compounds for in-vitro laboratory and scientific research only. Products are not for human or animal administration. Institutional researchers should confirm compliance with ethics approval requirements and applicable regulations.

Full legal guide: Are Research Peptides Legal in Australia? →

Safety overview: Research Peptide Safety & Side Effects: What the Science Says →

• Retatrutide 30mg, triple GLP-1/GIP/glucagon agonist; highest weight reduction in Phase 2 trials
• BPC-157 20mg, most widely studied tissue repair peptide; broad preclinical dataset
• Tirzepatide 30mg, approved dual GLP-1/GIP agonist; SURMOUNT-1 Phase 3 data
• NAD+ 100mg, mitochondrial cofactor; sirtuin and longevity pathway research
• MOTS-c 10mg, mitochondria-derived peptide; metabolic and exercise capacity research
• SS-31 10mg, cardiolipin-stabilising mitochondrial peptide; Phase 2/3 clinical data
• Ipamorelin 10mg, selective GHRP; clean GH secretion profile
• GHK-Cu 50mg, copper peptide; collagen synthesis and hair follicle research
• Semax 10mg, BDNF-upregulating nootropic neuropeptide; Russian clinical history
• BPC-157 + TB-500 Blend 10mg, tissue repair combination; complementary mechanisms